Maravai LifeSciences Holdings, Inc. Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
Maravai LifeSciences Holdings, Inc. (MRVI) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $7.21 million as of 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2025-11-07
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $7.21M.
- 2025-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $14.42M.
- 2025-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $21.57M.
- 2024-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $6.90M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2025-09-30 | $7.21M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $14.42M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $21.57M 10-Q · filed 2025-05-12 |
| 2024-09-30 | $6.90M 10-Q · filed 2024-11-12 |
| 2023-09-30 | $6.87M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $13.74M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $20.59M 10-Q · filed 2023-05-09 |
| 2022-09-30 | $6.24M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $12.49M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $18.74M 10-Q · filed 2022-05-06 |
| 2021-09-30 | $3.65M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $7.54M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $15.04M 10-Q · filed 2021-05-12 |